Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Netrin-4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivo.

Enoki Y, Sato T, Tanaka S, Iwata T, Usui M, Takeda S, Kokabu S, Matsumoto M, Okubo M, Nakashima K, Yamato M, Okano T, Fukuda T, Chida D, Imai Y, Yasuda H, Nishihara T, Akita M, Oda H, Okazaki Y, Suda T, Yoda T.

FEBS Lett. 2014 Jun 27;588(14):2262-9. doi: 10.1016/j.febslet.2014.05.009. Epub 2014 May 17.

2.

The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.

Idris AI, Landao-Bassonga E, Ralston SH.

Bone. 2010 Apr;46(4):1089-99. doi: 10.1016/j.bone.2010.01.368. Epub 2010 Jan 22.

PMID:
20096813
3.

Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.

Yonezawa T, Hasegawa S, Asai M, Ninomiya T, Sasaki T, Cha BY, Teruya T, Ozawa H, Yagasaki K, Nagai K, Woo JT.

Eur J Pharmacol. 2011 Jan 15;650(2-3):511-8. doi: 10.1016/j.ejphar.2010.10.048. Epub 2010 Nov 1.

PMID:
21047508
4.

Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.

Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH.

Eur J Pharmacol. 2009 Nov 25;623(1-3):22-9. doi: 10.1016/j.ejphar.2009.09.025. Epub 2009 Sep 17.

PMID:
19766111
5.

Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation.

Mediero A, Ramkhelawon B, Perez-Aso M, Moore KJ, Cronstein BN.

J Bone Miner Res. 2015 May;30(5):837-54. doi: 10.1002/jbmr.2421.

6.

Osteoclast culture and resorption assays.

Bradley EW, Oursler MJ.

Methods Mol Biol. 2008;455:19-35. doi: 10.1007/978-1-59745-104-8_2.

PMID:
18463808
7.

Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.

Lee JW, Kobayashi Y, Nakamichi Y, Udagawa N, Takahashi N, Im NK, Seo HJ, Jeon WB, Yonezawa T, Cha BY, Woo JT.

Biochem Pharmacol. 2010 Aug 1;80(3):352-61. doi: 10.1016/j.bcp.2010.04.014. Epub 2010 Apr 20.

PMID:
20412788
8.

Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.

Han KH, Ryu JW, Lim KE, Lee SH, Kim Y, Hwang CS, Choi JY, Han KO.

Bone. 2014 Apr;61:91-101. doi: 10.1016/j.bone.2013.12.032. Epub 2014 Jan 5.

PMID:
24401612
9.

MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.

Kim HN, Lee JH, Jin WJ, Ko S, Jung K, Ha H, Lee ZH.

Eur J Pharmacol. 2012 Sep 15;691(1-3):69-76. doi: 10.1016/j.ejphar.2012.07.034. Epub 2012 Jul 27.

PMID:
22846626
10.

Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.

Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J.

Biol Pharm Bull. 2009 Jul;32(7):1193-8.

11.

c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro.

Udagawa N, Chan J, Wada S, Findlay DM, Hamilton JA, Martin TJ.

Bone. 1996 Jun;18(6):511-6.

PMID:
8805990
13.

Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.

Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kobayashi Y, Nakamura H, Takahashi N, Udagawa N.

J Bone Miner Res. 2009 Aug;24(8):1469-80. doi: 10.1359/jbmr.090302.

15.

Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.

Li YJ, Kim TH, Kwak HB, Lee ZH, Lee SY, Jhon GJ.

J Ethnopharmacol. 2007 Sep 5;113(2):191-8. Epub 2007 May 16.

PMID:
17646068
16.

Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.

Kim MH, Ryu SY, Bae MA, Choi JS, Min YK, Kim SH.

Food Chem Toxicol. 2008 Nov;46(11):3375-82. doi: 10.1016/j.fct.2008.08.016. Epub 2008 Aug 26.

PMID:
18786594
17.

SNX10 is required for osteoclast formation and resorption activity.

Zhu CH, Morse LR, Battaglino RA.

J Cell Biochem. 2012 May;113(5):1608-15. doi: 10.1002/jcb.24029.

PMID:
22174188
18.

Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.

Sun L, Iqbal J, Dolgilevich S, Yuen T, Wu XB, Moonga BS, Adebanjo OA, Bevis PJ, Lund F, Huang CL, Blair HC, Abe E, Zaidi M.

FASEB J. 2003 Mar;17(3):369-75.

PMID:
12631576
19.

Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.

Takahashi M, Mizoguchi T, Uehara S, Nakamichi Y, Yang S, Naramoto H, Yamashita T, Kobayashi Y, Yamaoka M, Furusawa K, Udagawa N, Uematsu T, Takahashi N.

J Bone Miner Metab. 2009;27(1):24-35. doi: 10.1007/s00774-008-0013-y. Epub 2008 Dec 13.

PMID:
19082914
20.

A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.

Kim HJ, Yoon KA, Lee MK, Kim SH, Lee IK, Kim SY.

Life Sci. 2012 Nov 2;91(19-20):928-34. doi: 10.1016/j.lfs.2012.09.009. Epub 2012 Sep 20.

PMID:
23000100

Supplemental Content

Support Center